TAIYO KOSAN completes tender offer for Hisamitsu Pharmaceutical (¥6039.0000, -206)
StreetAccount Summary: Japan Stocks reaching new 52-week highs/lows (272 total)
Hisamitsu Pharmaceutical reports Q3 net income attributable ¥4.87B, +7% vs year-ago ¥4.56B
Hisamitsu Pharmaceutical endorses management buyout at ¥6,082/share (¥5200.0000, 0)
Powered by FactSet Research Systems Inc.